NEUVOGEN, Inc. ("NEUVOGEN THERAPEUTICS" or "NEUVOGEN"), a San Diego based biotechnology company, will present data that its next generation whole tumor cell vaccine (NGEN-143) activates T cells that ...

N-terminal acetylation dysregulation in the heart causes severe arrhythmia and cardiomyopathy. The authors show that stem cell models demonstrate ion channel trafficking defects and sarcomeric ...

The Factors Behind the Shifting Trends of Ischemic Heart Disease and Stroke Nov ... levels of methylmalonic acid and the weakening of CD8+ T cells, shedding light on potential pathways through ...

Heart and kidney transplant graft survival is suboptimal ... in the context of transplantation and immunosuppressive therapies: heterogeneity of human CD8+ T cell responses to antigens, mathematical ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

[29] Cao, Gollapudi, Sharman, Jia, and Gupta (2010) Age-related alterations of gene expression patterns in human CD8+ T ... Heart Circ Physiol, 6, H2698-704. [71] Chiarugi and Giannoni (2008) Anoikis: ...

NKG2D is characteristic for several types of cells such as NK cells or CD8+ αβ T cells, but also present in abundance on ... and can lead to severe complications involving the lungs, heart, kidneys, ...

A key enzyme and its molecular pathway are critical to keeping certain immune cells active and away from "exhaustion," ...

WEHI scientists have uncovered a promising new way to enhance the effectiveness of vaccines by tapping into the potential of a specific type of immune cell, opening the door to long-lasting vaccines ...